Serine protease signaling of epidermal permeability barrier homeostasis.

[1]  V. Rogiers,et al.  Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. , 2005, The Journal of investigative dermatology.

[2]  E. Diamandis,et al.  Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases , 2005, The British journal of dermatology.

[3]  K. Sandhoff,et al.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8 , 2005, The Journal of cell biology.

[4]  G. Cottrell,et al.  c-Cbl Mediates Ubiquitination, Degradation, and Down-regulation of Human Protease-activated Receptor 2* , 2005, Journal of Biological Chemistry.

[5]  H. Terashi,et al.  Interleukin-4 Suppresses the Enhancement of Ceramide Synthesis and Cutaneous Permeability Barrier Functions Induced by Tumor Necrosis Factor-α and interferon-γ in Human Epidermis , 2005 .

[6]  Rainer Schmidt,et al.  The cornified envelope: a model of cell death in the skin , 2005, Nature Reviews Molecular Cell Biology.

[7]  J. Trejo,et al.  Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.

[8]  S. Steinberg.  The Cardiovascular Actions of Protease-Activated Receptors , 2005, Molecular Pharmacology.

[9]  G. Zamolo,et al.  Perforin expression is upregulated in the epidermis of psoriatic lesions , 2004, The British journal of dermatology.

[10]  P. Chambon,et al.  Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. , 2004, The Journal of investigative dermatology.

[11]  T. Willson,et al.  The effect of LXR activators on AP-1 proteins in keratinocytes. , 2004, The Journal of investigative dermatology.

[12]  Connie B. Lin,et al.  The expression and activation of protease-activated receptor-2 correlate with skin color. , 2004, Pigment cell research.

[13]  M. Simon,et al.  Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. , 2004, The Journal of investigative dermatology.

[14]  M. Ghazizadeh,et al.  Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. , 2004, The Journal of investigative dermatology.

[15]  M. Seiberg,et al.  IL-41 The PAR-2 pathway is differentially Expressed in skin of color , 2003 .

[16]  C. Bodemer,et al.  LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. , 2003, Human molecular genetics.

[17]  T. Luger,et al.  Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivo , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Kaori Inoue,et al.  Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis. , 2003, The Journal of investigative dermatology.

[19]  K. Madison,et al.  Barrier function of the skin: "la raison d'être" of the epidermis. , 2003, The Journal of investigative dermatology.

[20]  L. Simonetti,et al.  Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin l2. , 2003, The Journal of investigative dermatology.

[21]  E. Christophers,et al.  Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis. , 2002, The Journal of investigative dermatology.

[22]  Kenneth R Feingold,et al.  Modulations in epidermal calcium regulate the expression of differentiation-specific markers. , 2002, The Journal of investigative dermatology.

[23]  P. Elias,et al.  Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. , 2002, Journal of the American Academy of Dermatology.

[24]  K. Sandhoff,et al.  Deficiency of Epidermal Protein-Bound ω-Hydroxyceramides in Atopic Dermatitis , 2002 .

[25]  P. Elias,et al.  Basis for the permeability barrier abnormality in lamellar ichthyosis , 2002, Experimental dermatology.

[26]  G. Scott,et al.  Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. , 2001, The Journal of investigative dermatology.

[27]  P. Elias,et al.  Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. , 2001, Archives of dermatology.

[28]  W. Pichler,et al.  Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis , 2001, The British journal of dermatology.

[29]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[30]  D. Bikle,et al.  Calcium- and vitamin D-regulated keratinocyte differentiation , 2001, Molecular and Cellular Endocrinology.

[31]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[32]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[33]  J. Auwerx,et al.  Stimulation of PPARα Promotes Epidermal Keratinocyte Differentiation In Vivo , 2000 .

[34]  J. Ring,et al.  Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. , 2000, Acta dermato-venereologica.

[35]  J. Karvonen,et al.  Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. , 2000, The Journal of investigative dermatology.

[36]  M. Krönke,et al.  Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. , 1999, The Journal of clinical investigation.

[37]  M. Brattsand,et al.  Purification, Molecular Cloning, and Expression of a Human Stratum Corneum Trypsin-like Serine Protease with Possible Function in Desquamation* , 1999, The Journal of Biological Chemistry.

[38]  U. Rassner,et al.  Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. , 1999, Tissue & cell.

[39]  M. Steinhoff,et al.  Proteinase‐activated receptor‐2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase , 1999, Experimental dermatology.

[40]  E. Choi,et al.  The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis. , 1999, The Journal of investigative dermatology.

[41]  N. Bunnett,et al.  Trafficking of Proteinase-activated Receptor-2 and β-Arrestin-1 Tagged with Green Fluorescent Protein , 1999, The Journal of Biological Chemistry.

[42]  P. Elias,et al.  Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. , 1998, The Journal of investigative dermatology.

[43]  U. Rassner,et al.  The secretory granular cell: the outermost granular cell as a specialized secretory cell. , 1998, The journal of investigative dermatology. Symposium proceedings.

[44]  M. Macey,et al.  Immunolocalization of protease‐activated receptor‐2 in skin: receptor activation stimulates interleukin‐8 secretion by keratinocytes in vitro , 1998, Immunology.

[45]  I. Arany,et al.  Isoforms of cathepsin D and human epidermal differentiation. , 1998, Biochimie.

[46]  P. Elias,et al.  Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. , 1997, The Journal of investigative dermatology.

[47]  P. Elias,et al.  trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. , 1997, The Journal of investigative dermatology.

[48]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[49]  P. Elias,et al.  Stratum corneum structure and function correlates with phenotype in psoriasis. , 1996, The Journal of investigative dermatology.

[50]  D. Payan,et al.  Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.

[51]  S. Seidenari,et al.  Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. , 1995, Acta dermato-venereologica.

[52]  A. Larsson,et al.  The Mouse Proteinase-activated Receptor-2 cDNA and Gene , 1995, The Journal of Biological Chemistry.

[53]  D. Roop,et al.  Defects in the barrier , 1995, Science.

[54]  P. Wallbrandt,et al.  Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. , 1994, The Journal of biological chemistry.

[55]  P. Elias,et al.  Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. , 1994, The Journal of investigative dermatology.

[56]  P. Elias,et al.  Fatty acids are required for epidermal permeability barrier function. , 1993, The Journal of clinical investigation.

[57]  F. Wiese,et al.  Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. , 1992, The Journal of investigative dermatology.

[58]  G. Imokawa,et al.  beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. , 1992, Journal of lipid research.

[59]  P. Elias,et al.  Lamellar body secretory response to barrier disruption. , 1992, The Journal of investigative dermatology.

[60]  P. Elias,et al.  Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis. , 1992, The Journal of investigative dermatology.

[61]  P. Elias,et al.  Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. , 1991, The Journal of clinical investigation.

[62]  J. Fairley.  Calcium metabolism and the pathogenesis of dermatologic disease. , 1991, Seminars in dermatology.

[63]  J. Pouysségur,et al.  cDNA cloning and expression of a hamster α‐thrombin receptor coupled to Ca2+ mobilization , 1991 .

[64]  P M Steinert,et al.  Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro , 1989, The Journal of cell biology.

[65]  P. Elias,et al.  Membrane structural alterations in murine stratum corneum: relationship to the localization of polar lipids and phospholipases. , 1988, The Journal of investigative dermatology.

[66]  P. Wertz,et al.  Lamellar granule extrusion and stratum corneum intercellular lamellae in murine keratinocyte cultures. , 1988, The Journal of investigative dermatology.

[67]  R. Isseroff,et al.  Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. , 1985, The Journal of investigative dermatology.

[68]  P. Elias,et al.  Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.

[69]  H. Maibach,et al.  In vivo transepidermal water loss and epidermal occlusive hydration in newborn infants: anatomical region variation. , 1980, Acta dermato-venereologica.

[70]  M. Brattsand,et al.  A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.

[71]  H. Maibach,et al.  Stratum Corneum pH in Atopic Dermatitis , 2004 .

[72]  S. Coughlin,et al.  PARticipation in inflammation. , 2003, The Journal of clinical investigation.

[73]  M. Taljebini,et al.  Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[74]  P. Elias,et al.  Secretory phospholipase A2 activity is required for permeability barrier homeostasis. , 1996, The Journal of investigative dermatology.

[75]  Jean-Claude Vatin,et al.  La raison d'être , 1992 .